The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

American Journal of Medicine

Volumn 112, Issue 5, 2002, Pages 380-385

  Bodey, Gerald P ^a   Mardani, Masoud ^a   Hanna, Hend A ^a   Boktour, Maha ^a   Abbas, Jalal ^a   Girgawy, Essam ^a   Hachem, Ray Y ^a   Kontoyiannis, Dimitrios P ^a   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CORTICOSTEROID; CYCLOSPORIN A; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FUNGEMIA; HEMATOLOGIC DISEASE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; NEUTROPENIA; PRIORITY JOURNAL; SEPSIS; THROMBOPHLEBITIS; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; APACHE; BONE MARROW TRANSPLANTATION; CANDIDA ALBICANS; CANDIDIASIS; CASE-CONTROL STUDIES; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0036532509     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)01130-5     Document Type: Article

References (21)

1. Importance of Candida species other than C. albicans as pathogen in oncology patients
2. Fungemia due to Torulopsis glabrata in the compromised host
3. The changing face of candidemia: Emergence of non-albicans species and antifungal resistance
4. National surveillance of nosocomial bloodstream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program
5. International surveillance of bloodstream infection due to Candida species
6. Hematogenous and major organ candidiasis
7. Candidemia in immunocompromised cancer patients
8. The epidemiology of hematogenous candidiasis caused by different Candida species
9. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients
10. Candida glabrata fungemia. Clinical features of 139 patients
11. Torulopsis glabrata infections in patients with cancer: Increasing incidence and relationship to colonization
12. Fluconazole resistance in Candida glabrata
13. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
14. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial
15. Apparent increase in frequency of infections involving Torulopsis glabrata: Procedure for its identification
16. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes
17. Candidemia in cancer patients: A prospective, multicenter surveillance study by the invasive fungal infection group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
18. Systemic candidiasis in cancer patients
19. Management of infections caused by Candida glabrata
20. Therapeutic approaches in patients with candidemia
21. Practice guidelines for the treatment of candidiasis